{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "06",
                "@timestamp": "2023-02-06T19:58:42.000042-05:00",
                "@year": "2023",
                "@month": "02"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Hemophilia Center"},
                {"xocs:funding-agency-matched-string": "Ratchadaphiseksomphot Endowment Fund"},
                {
                    "xocs:funding-agency-matched-string": "King Chulalongkorn Memorial Hospital",
                    "xocs:funding-agency": "King Chulalongkorn Memorial Hospital",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007693",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Takeda Pharmaceutical Company Limited",
                    "xocs:funding-agency-acronym": "TPC",
                    "xocs:funding-agency": "Takeda Pharmaceutical Company",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008373",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1861060/"
                },
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-acronym": "MDCU",
                    "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-02-01T06:05:16.588Z",
            "xocs:funding-text": [
                {"$": "This study was instigated and funded by Ratchadaphiseksomphot Endowment Fund, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. The authors would like to thank the Takeda Pharmaceutical Company Limited for supporting EHL FVIII concentrates and a PopPK software, myPKFiT®, for PK calculation. In addition, the authors were grateful to all the staff of Hemophilia Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, as part of the comprehensive hemophilia care team and for their dedication in PK evaluation."},
                {"$": "This study was instigated and funded by Ratchadaphiseksomphot Endowment Fund, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. The authors would like to thank the Takeda Pharmaceutical Company Limited for supporting EHL FVIII concentrates and a PopPK software, myPKFiT, for PK calculation. In addition, the authors were grateful to all the staff of Hemophilia Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, as part of the comprehensive hemophilia care team and for their dedication in PK evaluation. ®"}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Pediatric Hematology and Oncology"},
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183423"
                                },
                                {"@afid": "60028190"}
                            ],
                            "ce:source-text": "Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "103183423"
                        },
                        "author": [
                            {
                                "ce:given-name": "Arunothai",
                                "preferred-name": {
                                    "ce:given-name": "Arunothai",
                                    "ce:initials": "A.",
                                    "ce:surname": "Rakmanotham",
                                    "ce:indexed-name": "Rakmanotham A."
                                },
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Rakmanotham",
                                "@auid": "57212218736",
                                "ce:indexed-name": "Rakmanotham A."
                            },
                            {
                                "ce:given-name": "Darintr",
                                "preferred-name": {
                                    "ce:given-name": "Darintr",
                                    "ce:initials": "D.",
                                    "ce:surname": "Sosothikul",
                                    "ce:indexed-name": "Sosothikul D."
                                },
                                "@seq": "3",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sosothikul",
                                "@auid": "15830686100",
                                "@orcid": "0000-0003-1097-3482",
                                "ce:indexed-name": "Sosothikul D."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Integrative and Innovative Hematology/Oncology Research Unit"},
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183423"
                                },
                                {"@afid": "60028190"}
                            ],
                            "ce:source-text": "Integrative and Innovative Hematology/Oncology Research Unit, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "103183423"
                        },
                        "author": [
                            {
                                "ce:given-name": "Arunothai",
                                "preferred-name": {
                                    "ce:given-name": "Arunothai",
                                    "ce:initials": "A.",
                                    "ce:surname": "Rakmanotham",
                                    "ce:indexed-name": "Rakmanotham A."
                                },
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Rakmanotham",
                                "@auid": "57212218736",
                                "ce:indexed-name": "Rakmanotham A."
                            },
                            {
                                "ce:given-name": "Darintr",
                                "preferred-name": {
                                    "ce:given-name": "Darintr",
                                    "ce:initials": "D.",
                                    "ce:surname": "Sosothikul",
                                    "ce:indexed-name": "Sosothikul D."
                                },
                                "@seq": "3",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sosothikul",
                                "@auid": "15830686100",
                                "ce:indexed-name": "Sosothikul D."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of General Internal Medicine"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183427"
                                },
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "ce:source-text": "Division of General Internal Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "103183427"
                        },
                        "author": [{
                            "ce:given-name": "Chatphatai",
                            "preferred-name": {
                                "ce:given-name": "Chatphatai",
                                "ce:initials": "C.",
                                "ce:surname": "Moonla",
                                "ce:indexed-name": "Moonla C."
                            },
                            "@seq": "2",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Moonla",
                            "@auid": "34977270700",
                            "@orcid": "0000-0001-6257-0867",
                            "ce:indexed-name": "Moonla C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Translational Hematology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"},
                                {"$": "Bangkok"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "104136204"
                                },
                                {"@afid": "60028190"}
                            ],
                            "ce:source-text": "Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Bangkok, Thailand",
                            "@dptid": "104136204"
                        },
                        "author": [{
                            "ce:given-name": "Chatphatai",
                            "preferred-name": {
                                "ce:given-name": "Chatphatai",
                                "ce:initials": "C.",
                                "ce:surname": "Moonla",
                                "ce:indexed-name": "Moonla C."
                            },
                            "@seq": "2",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Moonla",
                            "@auid": "34977270700",
                            "ce:indexed-name": "Moonla C."
                        }]
                    }
                ],
                "citation-title": "Clinical outcomes of low-dose pharmacokinetic-guided extended half-life versus low-dose standard half-life factor VIII concentrate prophylaxis in haemophilia A patients",
                "abstracts": "© 2022 John Wiley & Sons Ltd.Introduction: Despite receiving standard half-life (SHL) factor VIII (FVIII) concentrates prophylaxis, some severe haemophilia A (HA) patients still encounter spontaneous breakthrough bleeding. Individualized pharmacokinetic (PK)-guided dosing of extended half-life (EHL) FVIII concentrates may reduce their bleeding events. Aim: To compare clinical outcomes before and after switching low-dose prophylaxis using weight-based SHL FVIII to PK-guided EHL FVIII concentrates, taking into consideration of a trough FVIII activity at 1 IU/dl above natural baseline. Methods: In this single-centre prospective cohort, Thai severe or moderate HA (FVIII activity ≤3 IU/dl) patients receiving low-dose weight-based SHL FVIII prophylaxis were enrolled. After a 3-day wash-out period, participants underwent low-dose EHL FVIII prophylaxis with PK-based adjustment (myPKFiT®) for 6 months. The annualized bleeding rates (ABR), the annualized joint bleeding rates (AJBR), the haemophilia-specific quality-of-life (Haemo-QoL or Haemo-QoL-A) scores, the Hemophilia Joint Health Scores (HJHS) and the annualized FVIII consumption were compared between the two prophylactic periods. Results: Of 15 eligible subjects (mean age 18.7 ± 6.7 years), ABR, AJBR and HJHS were significantly reduced (mean differences of -11.1 ± 4.9 bleeds/year, -10.4 ± 5.2 joint bleeds/year and -5.1 ± 1.5 marks, respectively; P <.001 for all comparisons) after switching regimen. The quality-of-life scores had also improved (P =.001). Nonetheless, FVIII consumption tended to increase despite no statistical significance (means of 1240.9 ± 531.3 SHL FVIII IU/kg/year versus 1591.7 ± 438.9 EHL FVIII IU/kg/year; P =.05). Conclusions: This is the first low-dose, PK-guided, EHL FVIII prophylaxis clinical study in Thailand. Benefits and practicability of this personalized regimen may support the implementation of regular FVIII prophylaxis in developing countries with budget constraints. ClinicalTrials.gov NCT05281185.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Pediatric Hematology and Oncology"},
                            {"$": "Department of Pediatrics"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Darintr",
                        "ce:initials": "D.",
                        "ce:surname": "Sosothikul",
                        "ce:indexed-name": "Sosothikul D."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "coagulation factor VIII",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "haemophilia A",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "pharmacokinetics",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "riroctocog alfa pegol",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Thailand",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2516",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Haemophilia",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "29",
                            "@issue": "1"
                        },
                        "pagerange": {
                            "@first": "156",
                            "@last": "164"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Haemophilia",
                    "publicationdate": {
                        "month": "01",
                        "year": "2023",
                        "date-text": "January 2023",
                        "day": "01"
                    },
                    "codencode": "HAEMF",
                    "sourcetitle-abbrev": "Haemophilia",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "13652516",
                            "@type": "electronic"
                        },
                        {
                            "$": "13518216",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "John Wiley and Sons Inc"},
                    "@srcid": "25963"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "30",
                                    "classification-description": "Clinical and Experimental Pharmacology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2720"},
                                {"$": "2716"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "tradenamegroup": {"tradenames": [
                        {
                            "trademanuitem": [
                                {
                                    "tradename": "advate",
                                    "manufacturer": {
                                        "@country": "usa",
                                        "$": "Baxter"
                                    }
                                },
                                {
                                    "tradename": "adynovate",
                                    "manufacturer": {
                                        "@country": "usa",
                                        "$": "Baxalta"
                                    }
                                }
                            ],
                            "@type": "TNM"
                        },
                        {
                            "trademanuitem": {
                                "tradename": "myPKFiT",
                                "manufacturer": {
                                    "@country": "usa",
                                    "$": "Baxalta"
                                }
                            },
                            "@type": "TNV"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "9001-27-8",
                                    "chemical-name": "blood clotting factor 8"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "1192451-26-5"},
                                        {"$": "1219013-68-9"},
                                        {"$": "1309086-46-1"},
                                        {"$": "1270012-79-7"},
                                        {"$": "1388129-63-2"},
                                        {"$": "1417412-83-9"},
                                        {"$": "1339940-90-7"},
                                        {"$": "2252477-42-0"}
                                    ],
                                    "chemical-name": "recombinant blood clotting factor 8"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Factor VIII"},
                                {"chemical-name": "Hemostatics"}
                            ]
                        }
                    ]},
                    "manufacturergroup": {"manufacturers": [
                        {
                            "@type": "MNF",
                            "manufacturer": [
                                {
                                    "@country": "usa",
                                    "$": "Baxalta"
                                },
                                {
                                    "@country": "usa",
                                    "$": "Baxter"
                                }
                            ]
                        },
                        {
                            "@type": "MNV",
                            "manufacturer": {
                                "@country": "usa",
                                "$": "Baxalta"
                            }
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was instigated and funded by Ratchadaphiseksomphot Endowment Fund, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. The authors would like to thank the Takeda Pharmaceutical Company Limited for supporting EHL FVIII concentrates and a PopPK software, myPKFiT®, for PK calculation. In addition, the authors were grateful to all the staff of Hemophilia Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, as part of the comprehensive hemophilia care team and for their dedication in PK evaluation.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "06",
                    "@timestamp": "BST 14:46:32",
                    "@year": "2023",
                    "@month": "02"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2020184493",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "639578170",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "944349564",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20221064481",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "36409282",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20223429224",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20224128516",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20229030019538",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85142452278",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85142452278",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "639578170",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76928099",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1111/hae.14700"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "17",
                "reference": [
                    {
                        "ref-fulltext": "White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85(3):560.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035077234",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "85",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "560"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.C.",
                                    "@_fa": "true",
                                    "ce:surname": "White",
                                    "ce:suffix": "2nd",
                                    "ce:indexed-name": "White G.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Rosendaal",
                                    "ce:indexed-name": "Rosendaal F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Aledort",
                                    "ce:indexed-name": "Aledort L.M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Lusher",
                                    "ce:indexed-name": "Lusher J.M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Rothschild",
                                    "ce:indexed-name": "Rothschild C."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Ingerslev",
                                    "ce:indexed-name": "Ingerslev J."
                                }
                            ]},
                            "ref-sourcetitle": "Thromb Haemost"
                        },
                        "ce:source-text": "White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85(3):560."
                    },
                    {
                        "ref-fulltext": "Weyand AC, Pipe SW. New therapies for hemophilia. Blood. 2019; 133(5):389-398.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "New therapies for hemophilia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85060874507",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "133",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "389",
                                    "@last": "398"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Weyand",
                                    "ce:indexed-name": "Weyand A.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Pipe",
                                    "ce:indexed-name": "Pipe S.W."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Weyand AC, Pipe SW. New therapies for hemophilia. Blood. 2019; 133(5):389-398."
                    },
                    {
                        "ref-fulltext": "Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535-544.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34547757915",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "357",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "535",
                                    "@last": "544"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Manco-Johnson",
                                        "ce:indexed-name": "Manco-Johnson M.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Abshire",
                                        "ce:indexed-name": "Abshire T.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Shapiro",
                                        "ce:indexed-name": "Shapiro A.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535-544."
                    },
                    {
                        "ref-fulltext": "Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26(Suppl 6):1-158.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "WFH guidelines for the management of hemophilia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092332111",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "158"
                                }
                            },
                            "ref-text": "(Suppl",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Srivastava",
                                        "ce:indexed-name": "Srivastava A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Santagostino",
                                        "ce:indexed-name": "Santagostino E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dougall",
                                        "ce:indexed-name": "Dougall A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26(Suppl 6):1-158."
                    },
                    {
                        "ref-fulltext": "Iorio A, Edginton AN, Blanchette V, et al. Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: rationale and general considerations. Res Pract Thromb Haemost. 2018;2(3):535-548.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: rationale and general considerations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059584992",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "535",
                                    "@last": "548"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Iorio",
                                        "ce:indexed-name": "Iorio A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Edginton",
                                        "ce:indexed-name": "Edginton A.N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Blanchette",
                                        "ce:indexed-name": "Blanchette V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Res Pract Thromb Haemost"
                        },
                        "ce:source-text": "Iorio A, Edginton AN, Blanchette V, et al. Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: rationale and general considerations. Res Pract Thromb Haemost. 2018;2(3):535-548."
                    },
                    {
                        "ref-fulltext": "Nagao A, Yeung CHT, Germini F, Suzuki T. Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing. Thromb Res. 2019;173:79-84.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057081676",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "173"},
                                "pagerange": {
                                    "@first": "79",
                                    "@last": "84"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Nagao",
                                    "ce:indexed-name": "Nagao A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.H.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Yeung",
                                    "ce:indexed-name": "Yeung C.H.T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Germini",
                                    "ce:indexed-name": "Germini F."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Suzuki",
                                    "ce:indexed-name": "Suzuki T."
                                }
                            ]},
                            "ref-sourcetitle": "Thromb Res"
                        },
                        "ce:source-text": "Nagao A, Yeung CHT, Germini F, Suzuki T. Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing. Thromb Res. 2019;173:79-84."
                    },
                    {
                        "ref-fulltext": "Valentino LA, Mamonov V, Hellmann A, et al. A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management. J Thromb Haemost. 2012;10(3):359-367.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84857572936",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "359",
                                    "@last": "367"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Valentino",
                                        "ce:indexed-name": "Valentino L.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Mamonov",
                                        "ce:indexed-name": "Mamonov V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hellmann",
                                        "ce:indexed-name": "Hellmann A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thromb Haemost"
                        },
                        "ce:source-text": "Valentino LA, Mamonov V, Hellmann A, et al. A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management. J Thromb Haemost. 2012;10(3):359-367."
                    },
                    {
                        "ref-fulltext": "Lindvall K, Astermark J, Björkman S, et al. Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy. Haemophilia. 2012;18(6):855-859.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84868206189",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "855",
                                    "@last": "859"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Lindvall",
                                        "ce:indexed-name": "Lindvall K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Astermark",
                                        "ce:indexed-name": "Astermark J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Björkman",
                                        "ce:indexed-name": "Bjorkman S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Lindvall K, Astermark J, Björkman S, et al. Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy. Haemophilia. 2012;18(6):855-859."
                    },
                    {
                        "ref-fulltext": "Hermans C, Mahlangu J, Booth J, et al. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII. Haemophilia. 2018;24(3):376-384.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85046414048",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "376",
                                    "@last": "384"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hermans",
                                        "ce:indexed-name": "Hermans C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mahlangu",
                                        "ce:indexed-name": "Mahlangu J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Booth",
                                        "ce:indexed-name": "Booth J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Hermans C, Mahlangu J, Booth J, et al. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII. Haemophilia. 2018;24(3):376-384."
                    },
                    {
                        "ref-fulltext": "Collins PW. Personalized prophylaxis. Haemophilia. 2012;18(4):131-135. Suppl.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Personalized prophylaxis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84862872608",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "131",
                                    "@last": "135"
                                }
                            },
                            "ref-text": "Suppl",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "P.W.",
                                "@_fa": "true",
                                "ce:surname": "Collins",
                                "ce:indexed-name": "Collins P.W."
                            }]},
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Collins PW. Personalized prophylaxis. Haemophilia. 2012;18(4):131-135. Suppl."
                    },
                    {
                        "ref-fulltext": "Ahlberg A. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand. 1965;77(Suppl):3-132. Suppl.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1965"},
                            "ref-title": {"ref-titletext": "Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0013836217",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "77"},
                                "pagerange": {
                                    "@first": "3",
                                    "@last": "132"
                                }
                            },
                            "ref-text": "(Suppl), Suppl",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Ahlberg",
                                "ce:indexed-name": "Ahlberg A."
                            }]},
                            "ref-sourcetitle": "Acta Orthop Scand"
                        },
                        "ce:source-text": "Ahlberg A. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand. 1965;77(Suppl):3-132. Suppl."
                    },
                    {
                        "ref-fulltext": "Fischer K, Collins PW, Ozelo MC, Srivastava A, Young G, Blanchette VS. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH. J Thromb Haemost. 2016;14(5):1105-1109.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84963795622",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1105",
                                    "@last": "1109"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Fischer",
                                    "ce:indexed-name": "Fischer K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Collins",
                                    "ce:indexed-name": "Collins P.W."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Ozelo",
                                    "ce:indexed-name": "Ozelo M.C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Srivastava",
                                    "ce:indexed-name": "Srivastava A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Young",
                                    "ce:indexed-name": "Young G."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "V.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Blanchette",
                                    "ce:indexed-name": "Blanchette V.S."
                                }
                            ]},
                            "ref-sourcetitle": "J Thromb Haemost"
                        },
                        "ce:source-text": "Fischer K, Collins PW, Ozelo MC, Srivastava A, Young G, Blanchette VS. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH. J Thromb Haemost. 2016;14(5):1105-1109."
                    },
                    {
                        "ref-fulltext": "Lane SJ, Walker I, Chan AK, et al. Treatment decision-making among Canadian youth with severe haemophilia: a qualitative approach. Haemophilia. 2015;21(2):180-189.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Treatment decision-making among Canadian youth with severe haemophilia: a qualitative approach"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84923008486",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "180",
                                    "@last": "189"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lane",
                                        "ce:indexed-name": "Lane S.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Walker",
                                        "ce:indexed-name": "Walker I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan A.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Lane SJ, Walker I, Chan AK, et al. Treatment decision-making among Canadian youth with severe haemophilia: a qualitative approach. Haemophilia. 2015;21(2):180-189."
                    },
                    {
                        "ref-fulltext": "Mingot-Castellano ME, Parra R, Núñez R, Martorell M. Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®. Haemophilia. 2018;24(5):e338.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85050498247",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "24",
                                "@issue": "5"
                            }},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Mingot-Castellano",
                                    "ce:indexed-name": "Mingot-Castellano M.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Parra",
                                    "ce:indexed-name": "Parra R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Núñez",
                                    "ce:indexed-name": "Nunez R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Martorell",
                                    "ce:indexed-name": "Martorell M."
                                }
                            ]},
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Mingot-Castellano ME, Parra R, Núñez R, Martorell M. Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®. Haemophilia. 2018;24(5):e338."
                    },
                    {
                        "ref-fulltext": "Collins PW, Blanchette VS, Fischer K, et al. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. J Thromb Haemost. 2009;7(3):413-420.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "59849093369",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "413",
                                    "@last": "420"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Collins",
                                        "ce:indexed-name": "Collins P.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Blanchette",
                                        "ce:indexed-name": "Blanchette V.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Fischer",
                                        "ce:indexed-name": "Fischer K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thromb Haemost"
                        },
                        "ce:source-text": "Collins PW, Blanchette VS, Fischer K, et al. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. J Thromb Haemost. 2009;7(3):413-420."
                    },
                    {
                        "ref-fulltext": "Sun HL, McIntosh KA, Squire SJ, et al. Patient powered prophylaxis: a 12-month study of individualized prophylaxis in adults with severe haemophilia A. Haemophilia. 2017;23(6):877-883.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Patient powered prophylaxis: a 12-month study of individualized prophylaxis in adults with severe haemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034261329",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "877",
                                    "@last": "883"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Sun",
                                        "ce:indexed-name": "Sun H.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.A.",
                                        "@_fa": "true",
                                        "ce:surname": "McIntosh",
                                        "ce:indexed-name": "McIntosh K.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Squire",
                                        "ce:indexed-name": "Squire S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Sun HL, McIntosh KA, Squire SJ, et al. Patient powered prophylaxis: a 12-month study of individualized prophylaxis in adults with severe haemophilia A. Haemophilia. 2017;23(6):877-883."
                    },
                    {
                        "ref-fulltext": "Crivianu-Gaita V, Rivard GE, Carcao M, Teitel J, St-Louis J, Blanchette V, et al. Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A. Haemophilia. 2016;22(5):e401-5.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "hae14700-cit-0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84990216923",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "e401",
                                    "@last": "e405"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Crivianu-Gaita",
                                        "ce:indexed-name": "Crivianu-Gaita V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Rivard",
                                        "ce:indexed-name": "Rivard G.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Carcao",
                                        "ce:indexed-name": "Carcao M."
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Teitel",
                                        "ce:indexed-name": "Teitel J."
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "St-Louis",
                                        "ce:indexed-name": "St-Louis J."
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Blanchette",
                                        "ce:indexed-name": "Blanchette V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haemophilia"
                        },
                        "ce:source-text": "Crivianu-Gaita V, Rivard GE, Carcao M, Teitel J, St-Louis J, Blanchette V, et al. Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A. Haemophilia. 2016;22(5):e401-5."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85142452278",
        "dc:description": "Introduction: Despite receiving standard half-life (SHL) factor VIII (FVIII) concentrates prophylaxis, some severe haemophilia A (HA) patients still encounter spontaneous breakthrough bleeding. Individualized pharmacokinetic (PK)-guided dosing of extended half-life (EHL) FVIII concentrates may reduce their bleeding events. Aim: To compare clinical outcomes before and after switching low-dose prophylaxis using weight-based SHL FVIII to PK-guided EHL FVIII concentrates, taking into consideration of a trough FVIII activity at 1 IU/dl above natural baseline. Methods: In this single-centre prospective cohort, Thai severe or moderate HA (FVIII activity ≤3 IU/dl) patients receiving low-dose weight-based SHL FVIII prophylaxis were enrolled. After a 3-day wash-out period, participants underwent low-dose EHL FVIII prophylaxis with PK-based adjustment (myPKFiT®) for 6 months. The annualized bleeding rates (ABR), the annualized joint bleeding rates (AJBR), the haemophilia-specific quality-of-life (Haemo-QoL or Haemo-QoL-A) scores, the Hemophilia Joint Health Scores (HJHS) and the annualized FVIII consumption were compared between the two prophylactic periods. Results: Of 15 eligible subjects (mean age 18.7 ± 6.7 years), ABR, AJBR and HJHS were significantly reduced (mean differences of -11.1 ± 4.9 bleeds/year, -10.4 ± 5.2 joint bleeds/year and -5.1 ± 1.5 marks, respectively; P <.001 for all comparisons) after switching regimen. The quality-of-life scores had also improved (P =.001). Nonetheless, FVIII consumption tended to increase despite no statistical significance (means of 1240.9 ± 531.3 SHL FVIII IU/kg/year versus 1591.7 ± 438.9 EHL FVIII IU/kg/year; P =.05). Conclusions: This is the first low-dose, PK-guided, EHL FVIII prophylaxis clinical study in Thailand. Benefits and practicability of this personalized regimen may support the implementation of regular FVIII prophylaxis in developing countries with budget constraints. ClinicalTrials.gov NCT05281185.",
        "pubmed-id": "36409282",
        "prism:coverDate": "2023-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85142452278",
        "dc:creator": {"author": [{
            "ce:given-name": "Arunothai",
            "preferred-name": {
                "ce:given-name": "Arunothai",
                "ce:initials": "A.",
                "ce:surname": "Rakmanotham",
                "ce:indexed-name": "Rakmanotham A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Rakmanotham",
            "@auid": "57212218736",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212218736",
            "ce:indexed-name": "Rakmanotham A."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85142452278"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85142452278&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85142452278&origin=inward"
            }
        ],
        "source-id": "25963",
        "citedby-count": "0",
        "prism:volume": "29",
        "subtype": "ar",
        "dc:title": "Clinical outcomes of low-dose pharmacokinetic-guided extended half-life versus low-dose standard half-life factor VIII concentrate prophylaxis in haemophilia A patients",
        "openaccess": "0",
        "prism:issn": "13652516 13518216",
        "publishercopyright": "© 2022 John Wiley & Sons Ltd.",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Haemophilia",
        "prism:pageRange": "156-164",
        "prism:endingPage": "164",
        "openaccessFlag": "false",
        "prism:doi": "10.1111/hae.14700",
        "prism:startingPage": "156",
        "dc:identifier": "SCOPUS_ID:85142452278",
        "dc:publisher": "John Wiley and Sons Inc"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adolescent",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Child",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Factor VIII",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Half-Life",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hemarthrosis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hemophilia A",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Hemorrhage",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hemostatics",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Quality of Life",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Young Adult",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "coagulation factor VIII"
        },
        {
            "@_fa": "true",
            "$": "haemophilia A"
        },
        {
            "@_fa": "true",
            "$": "pharmacokinetics"
        },
        {
            "@_fa": "true",
            "$": "riroctocog alfa pegol"
        },
        {
            "@_fa": "true",
            "$": "Thailand"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Genetics (clinical)",
            "@code": "2716",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Arunothai",
            "preferred-name": {
                "ce:given-name": "Arunothai",
                "ce:initials": "A.",
                "ce:surname": "Rakmanotham",
                "ce:indexed-name": "Rakmanotham A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Rakmanotham",
            "@auid": "57212218736",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212218736",
            "ce:indexed-name": "Rakmanotham A."
        },
        {
            "ce:given-name": "Chatphatai",
            "preferred-name": {
                "ce:given-name": "Chatphatai",
                "ce:initials": "C.",
                "ce:surname": "Moonla",
                "ce:indexed-name": "Moonla C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                }
            ],
            "ce:surname": "Moonla",
            "@auid": "34977270700",
            "author-url": "https://api.elsevier.com/content/author/author_id/34977270700",
            "ce:indexed-name": "Moonla C."
        },
        {
            "ce:given-name": "Darintr",
            "preferred-name": {
                "ce:given-name": "Darintr",
                "ce:initials": "D.",
                "ce:surname": "Sosothikul",
                "ce:indexed-name": "Sosothikul D."
            },
            "@seq": "3",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Sosothikul",
            "@auid": "15830686100",
            "author-url": "https://api.elsevier.com/content/author/author_id/15830686100",
            "ce:indexed-name": "Sosothikul D."
        }
    ]}
}}